Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4572699
Max Phase: Preclinical
Molecular Formula: C23H20FN3O3
Molecular Weight: 405.43
Molecule Type: Unknown
Associated Items:
ID: ALA4572699
Max Phase: Preclinical
Molecular Formula: C23H20FN3O3
Molecular Weight: 405.43
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc2cc(F)ccc2n1
Standard InChI: InChI=1S/C23H20FN3O3/c1-15-14-26(22(29)16-5-3-2-4-6-16)11-12-27(15)23(30)21(28)20-9-7-17-13-18(24)8-10-19(17)25-20/h2-10,13,15H,11-12,14H2,1H3
Standard InChI Key: PYVXYTRWQSRAAA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.43 | Molecular Weight (Monoisotopic): 405.1489 | AlogP: 2.93 | #Rotatable Bonds: 3 |
Polar Surface Area: 70.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.26 | CX LogP: 3.16 | CX LogD: 3.16 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.50 | Np Likeness Score: -1.51 |
1. Wang T, Wallace OB, Zhang Z, Fang H, Yang Z, Robinson BA, Spicer TP, Gong YF, Blair WS, Shi PY, Lin PF, Deshpande M, Meanwell NA, Kadow JF.. (2019) A survey of core replacements in indole-based HIV-1 attachment inhibitors., 29 (11): [PMID:30940396] [10.1016/j.bmcl.2019.03.018] |
Source(1):